feed,title,long_url,short_url
Benzinga,Mesoblast Phase 3 Trial Shows That a Single Injection of Rexlemestrocel-L + Hyaluronic Acid Carrier Results in at Least Two Years of Pain Reduction With Opioid Sparing Activity in Patients With Chronic Low Back Pain Due to Degenerative Disc Disease,https://www.benzinga.com/pressreleases/21/02/g19603730/mesoblast-phase-3-trial-shows-that-a-single-injection-of-rexlemestrocel-l-hyaluronic-acid-carrier-,https://j.mp/3tFwVgi
Benzinga,General Cannabis Corp Expands Convertible Financing Round and Adds Additional Capital Partner,https://www.benzinga.com/pressreleases/21/02/g19603720/general-cannabis-corp-expands-convertible-financing-round-and-adds-additional-capital-partner,https://j.mp/3rGeHcL
